Optical Coherence Tomography (OCT)
Device
Abbott Laboratories
Total Payments
$2.1M
Transactions
204
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $2.1M | 204 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.1M | 204 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized Trial in PCI | Abbott Laboratories | $2.1M | 0 |
| Optical Coherence Tomography (OCT) Compared to Intravascular Ultrasound (IVUS) and Angiography to Guide Coronary Stent Implantation: a Multicenter Randomized Trial in PCI | Abbott Laboratories | $500.00 | 0 |
Top Doctors Receiving Payments for Optical Coherence Tomography (OCT)
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $2.1M | 204 |
Ad
Manufacturing Companies
- Abbott Laboratories $2.1M
Product Information
- Type Device
- Total Payments $2.1M
- Total Doctors 0
- Transactions 204
About Optical Coherence Tomography (OCT)
Optical Coherence Tomography (OCT) is a device associated with $2.1M in payments to 0 healthcare providers, recorded across 204 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $2.1M was paid across 204 transactions to 0 doctors.
The most common payment nature for Optical Coherence Tomography (OCT) is "Unspecified" ($2.1M, 100.0% of total).
Optical Coherence Tomography (OCT) is associated with 2 research studies, including "Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized Trial in PCI" ($2.1M).